Acute stress has been shown to modify hypothalamus-pituitary-gonadal (HPG) axis activity.
Introduction
Recent publications define stress as a conscious or unconscious threat to homeostasis, in which the response has a degree of specificity. The body possesses several homeostatic systems to maintain the values of physiological variables in acceptable ranges despite internal and external stressors. A typical feature of the stress response is the activation of the autonomic nervous system and the hypothalamus-pituitary-adrenal (HPA) axis (Goldstein and Kopin, 2007; Goldstein and McEwen, 2002; Pacak, 2000) . Exposure to stressful stimuli can lead to a variety of secondary effects in the cardiovascular, gastrointestinal, immune, nervous, and reproductive systems (Chrousos, 2009) . Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are the gonadotropins that drive follicular development, estrogen (E 2 ) and progesterone secretion (P), estrous cyclicity, and ovulation. It is generally accepted that chronic stress is a potent inhibitor of reproductive function (Wingfield and Sapolsky, 2003) . Nonetheless, acute stress may inhibit or activate the HPG axis depending on background E 2 priming. In this way under adequate E 2 levels acute stressors or acute ACTH treatment could increase LH and FSH secretion and then facilitate the reproduction. It has been shown that adrenal steroids mediate this effect (Brann and Mahesh, 1991; Marti and Armario, 1998) . There is substantial evidence for interaction between ovarian and adrenal steroids to control the gonadotropin secretion (Mahesh and Brann, 1992) . The secretion of ACTH and corticosterone (Buckingham et al., 1978) and adrenal progesterone (Shaikh and Shaikh, 1975 ) increases on proestrus afternoon compared to the other days of the estrous cycle. Adrenalectomy causes irregular cyclicity and a prolonged period of asynchronic gonadotropin surges that can be reversed by progesterone replacement (Mann et al., 1975) . In addition, it decreases ovarian follicle development (Peppler and Jacobs, 1976) .
The mechanisms through which stressors impact the hypothalamus-pituitary-gonadal (HPG) axis are becoming better understood. It is well-established that corticotrophinreleasing hormone (CRH), the principal factor that drives the HPA axis during stress, is a potent inhibitor of the gonadotropin-releasing hormone (GnRH) pulse generator. Central administration of CRH inhibits LH pulses (Rivier and Vale, 1984) . In addition, the suppression of LH secretion by a variety of stressful stimuli can be reversed by CRH antagonists (Rivier and Rivest, 1991) .
The physiological effects of CRH receptors are mediated via the CRH-R 1 and CRH-R 2 subtypes, which have a heterogeneous distribution pattern in the brain and a distinct physiopharmacology that suggests differential functional roles (Hillhouse and Grammatopoulos, 2006) . The role of the CRH receptors on the suppression of the stress-induced LH pulses depends on the nature of the stressor (Li et al., 2006) .
In female rats, E 2 is widely accepted to be a hormone that regulates prolactin (PRL) secretion and increases the number of lactotrophs (Grattan and Kokay, 2008) . Various models of stress are known to induce hyperprolactinemia, which in turn, could interfere with reproductive functions, including gonadotropin secretion (Freeman et al., 2000) . Stress-induced hyperprolactinemia appears to be mediated by a central action of CRH because it can be reversed by a central administration of a CRH antagonist (Akema et al., 1995) ; however, the subtype of the receptor that is being inhibited is still unknown.
Non-peptide selective CRH-R 1 receptor antagonists, such as CP 154,526 (Chen et al., 1997) and antalarmin (Webster et al., 1996) , are useful tools for discovering the role of CRH-R 1 receptors during stress. Antalarmin crosses the blood brain barrier (Habib et al., 2000) and i.v. injection of this compound decreases the activity of the HPA axis in experimental models using physical and behavioral stress (Jutkiewicz et al., 2005; Myers et al., 2005) . Antalarmin blocks the anxiogenic action of CRH in rats, as showed by studies using an elevated plus maze (Zorrilla et al., 2002) or impairs the acquisition and maintenance of conditioned fear responses (Deak et al., 1999) . In nonhuman primates, the i.v. administration of antalarmin decreases behavioral anxiety responses, ACTH levels, and cortisol levels (French et al., 2007; Habib et al., 2000) . Thus, antalarmin reduces activity of the HPA axis and attenuates the fear and anxiety states in animal models. However, its effect on the HPG and PRL axes has not yet been investigated. In summary, considering the evidences of interaction between ovarian and adrenal steroids to control the gonadotropin secretion, the effects of stress on HPG axis, the effects of estrogen and stress on PRL secretion; the present study was designed to investigate whether the acute restraint stress effects on the HPA, PRL and HPG axes in estrogenprimed rats can be reversed by a selective CRF-R 1 receptor antagonist.
Results

2.1.
Effects of acute stress on hormonal secretion in estrogen-primed rats
The plasma concentrations of LH, PRL, FSH, CT and P obtained in both experiments are shown in Figs. 1-5, respectively. After restraint stress the LH secretion increased rapidly to reach a peak about 30-40 times its initial value keeping this level for 3 h (from 11:00 h to 14:00 h) (F 6,288 =4.73, p =0.001) (Fig. 1A ). This increase was followed by a decrease in the afternoon (Fig. 1B) when the LH secretion normally should be higher due to the E 2 stimulatory effect (F 6,288 =6.72, p = <0.0001) with a final peak at 18:00 h. The CT and P levels increased rapidly and returned to basal levels at 14:00 h or forward (F 6,288 = 14.17, p =<0.0001 and F 6,288 =8.15, p = <0.0001 respectively) (Figs. 4, 5 ).
In the stress group, the increase of PRL secretion was minor at 14:00 h (F 6,288 =3.89, p = 0.0009) and higher after 16:00 h when compared with the vehicle non-stress group (F 6,288 =8.15, p =<0.0001) (Fig. 2) . The morning concentrations of FSH were not affected by the stress procedure (Fig. 3A ) (F 6,288 =0.95, p=0.5387) . The FSH surge that was induced by E 2 at 17:00 h was not observed in the restraint stress group (Fig. 3B) The intravenous administration of the CRH-R 1 specific antagonist (antalarmin, 1 and 0.1 mg/kg) 20 min before the onset of the restraint stress significantly attenuated the stimulatory effect of this stress on LH secretion during the time period from 11:00 h to 14:00 h (F 2,288 =7.51, p =0.0007) (Fig. 1A) . However, the LH surge alteration induced by stress was not modified by antalarmin (Fig. 1B) (F 12,288 =1.44, p =0.1462) . The CRH-R 1 antagonist decreased the CT and P secretion induced by restraint stress (F 12,288 = 1.80, p = 0.048 and F 2,288 = 4.85, p = 0.0085 respectively) (Figs. 4, 5) . In addition, this antagonist blocked the PRL secretion alterations induced by stress (F 12,288 = 2.06, p = 0.0197) (Fig. 2) . The administration of a CRH-R 1 antagonist did not alter the suppression stress-induced of the FSH surge at 17:00 h (F 12,288 = 0.51, p = 0.9051).
Discussion
Our results showed, for the first time, that CRH-R 1 plays a key role in the stress-induced stimulatory effects on LH secretion. Peripheral administration of the selective CRH-R 1 antagonist, antalarmin, attenuated the restraint stress-induced increase of LH secretion in E 2 -primed ovariectomized rats. In addition, we showed for the first time that the effects of restraint stress on P and PRL secretion are mediated, at least in part, by CRH-R 1 . Antalarmin decreased the P secretion and biphasic PRL pattern induced by restraint stress when compared with control group. Although it is well established that chronic stress exerts an inhibitory action on the HPG axis at central or peripheral levels (Rivier and Rivest, 1991) , there is little information about which mechanisms are involved in the acute stress effects on the HPG axis. Previous studies in female rats (Briski and Sylvester, 1988; Kam et al., 2000) , pigs (Einarsson et al., 2008) , non-human primates (Xiao et al., 1994) , humans (Puder et al., 2000) and a recent review about acute stress and ovulation, pointed out that positive responses of the HPG axis are found under relatively high plasma levels of E 2 (Tarin et al., 2010) . The researchers observed that acute stressors applied for rats on the morning of proestrus, E 2 -treated female rats, Rhesus monkeys during the mid-follicular and mid-luteal phases or women during the mid-follicular phase can facilitate LH secretion and consequently the ovulation. Our study extends this information showing that restraint stress for 40 min initially causes a stimulation of the HPG axis, which is followed by decreased pattern of secretion of LH induced normally by E 2 replacement. Afternoon plasma LH levels only reach a peak at the end of the experiment. Our experimental design do not allow to conclude if LH surge was delayed completely or partially inhibited by restraint stress, because we withdrew blood samples until 1800 h. These timing-effects may be related to the duration of the exposure to a stressor because continuous restraint stress abolishes the normal LH secretion (Kam et al., 2000) . Nonetheless, the stress-induced stimulatory effect on the LH secretion depends on CRH-R 1 antagonism. Other researchers have shown that CRH receptors have different participation in Fig. 1 -Effects of restraint stress (40 min) on luteinizing hormone (LH) secretion in estrogen-primed ovariectomized rats previously treated with antalarmin (0.1 or 1 mg/kg i.v.) or vehicle. As control, a group no-stress was treated with vehicle. A (from 10 to 14 h) and B (from 10 to 18 h). Data are shown as mean ± SEM and were analyzed using a Mixed Linear Model. Significant differences: * stress vs. antalarmin and the control vehicle groups (p < 0.001); † control vehicle vs. antalarmin (p < 0.05); # control vehicle vs. stress and the antalarmin groups (p < 0.05). Group size = 10 animals. Fig. 2 -Effects of restraint stress (40 min) on prolactin (PRL) secretion in estrogen-primed ovariectomized rats previously treated with antalarmin (0.1 or 1 mg/kg i.v.) or vehicle. As control, a group no-stress was treated with vehicle. A (from 10 to 14 h) and B (from 10 to 18 h). Data are shown as mean ± SEM and were analyzed using a Mixed Linear Model. Significant differences: *stress vs. antalarmin and the control vehicle groups (p < 0.05); † control vehicle vs. antalarmin groups (p < 0.05). Group size = 10 animals. the restoration of LH secretion suppressed by stress, as CRH-R 1 mediates the response to restraint stress, whereas CRH-R 2 mediates the response to hypoglycemia and immunological stress (Li et al., 2005 (Li et al., , 2006 . Therefore, the stress-induced LH surge modification in our animals may have been mediated by CRH-R 2 rather than CRH-R 1 . In fact, data from our laboratory (yet unpublished) support this hypothesis.
Studies that used the swing-forced test model have reported that antalarmin modulates the CRH receptors in the locus coeruleus (LC) (Reyes et al., 2008) . The LC, one of the principal sources of noradrenaline in the brain, is highly responsive to stress (Conti et al., 1997) . It exerts a key role on LH secretion (Anselmo-Franci et al., 1997), expresses CRH-R 1 receptors (Sauvage and Steckler, 2001 ) and projects to the medial preoptic area (MPOA) (Campbell and Herbison, 2007) , where a subpopulation of GnRH neurons is activated by noradrenaline in presence of E 2 (Etgen, 2003; Herbison, 1997) . Thus, our laboratory is currently testing the hypothesis that antalarmin attenuates the stress-induced LH secretion due to a direct antagonism of the CRH-R 1 receptors in noradrenergic LC neurons. The E 2 -induced FSH and LH surges that occur at afternoon are altered by restraint stress. The effect of suppression on gonadotropin secretion has been reported earlier in E 2 -primed ovariectomized rats (Briski and Sylvester, 1988; Kam et al., 2000) submitted to different acute stressors and in cycling rats under restraint stress by 5 h (Roozendaal et al., 1995) . There are strong evidences that chronic stress inhibits the HPG axis activity via HPA axis. The mechanisms for this response include direct (Dudas and Merchenthaler, 2002; MacLusky et al., 1988) and indirect inhibitory projections from CRH neurons to GnRH neurons (Rivest et al., 1993) . Moreover, the released glucocorticoids act at three different levels: 1) hypothalamus, on synthesis and release of GnRH; 2) pituitary, decreasing the synthesis and release of LH and FSH; 3) gonad, hindering the stimulatory effect of the gonadotropins on steroidogenesis; (Breen and Karsch, 2004; Kalantaridou et al., 2004; Rivier and Rivest, 1991) .
It is generally accepted that chronic stress is a potent inhibitor of reproductive function (Wingfield and Sapolsky, 2003) . The organisms are prepared to inhibit reproductive function and mobilize the energy to vital systems during chronic stress. On the other hand, the facilitation of HPG axis activity during acute stress is not so obvious. Coitus-induced preovulatory LH surge has been characterized in several species (for instance, rabbits, voles, cats, ferrets and camels) in contrast with other species that present spontaneous ovulation (rats, sheep, monkeys and humans). The exceptional occurrence of induced ovulation in these later animals has motivated the hypothesis that induced ovulation is a primitive characteristic from which evolved the spontaneous ovulation (Jochle, 1975) . Mammalian species including human can show reproductive facilitation under specific occasions (see review Bakker and Baum, 2000) . Interestingly, our study showed difference between FSH and LH secretion in response to stress in the morning. This difference was documented decades ago after the use of several animal models (Du et al., 1979; McCann et al., 1983 ) and more recently during the evaluation of the gonadotropins secretion in ewes (Padmanabhan et al., 2003) or after CT treatment in male and female rats (Gore et al., 2006) . These results support the existence of independent control systems that drive the FSH-and LH-induced stress responses. Our data indicate that there is a dissociation of the mechanisms for the secretion of FSH and LH in response to restraint stress in the morning but not in the afternoon. The role of this dissociation is not yet clear and it will depend on other studies.
PRL secretion is greatly altered by a large number of stressful stimuli (Freeman et al., 2000) . Stress increases PRL secretion when its levels are near basal and decreases the PRL levels when they are already elevated (Gala, 1990) . In our study, the E 2 -induced PRL surge was delayed by acute restraint stress. This effect was blocked by the administration of antalarmin, indicating that CRH may mediate this response through CRH-R 1 . PRL secretion is predominantly under the tonic inhibitory control of hypothalamic dopamine, which is the primary PRL inhibiting factor (Ben-Jonathan and Hnasko, 2001). Data from other laboratories have shown that the inhibition of PRL secretion during immobilization stress is correlated with an increase in dopamine D 2 receptors in the pituitary gland (Kam et al., 2000) . It has also been shown that antalarmin reversed the up-regulation of dopamine D 2 receptors in the amygdala and nucleus accumbens (Djouma et al., 2006 ) of animals exposed to the social isolation stress. Taken together, these data suggest that CRH may modulate the dopaminergic system through CRH-R 1 to control PRL secretion that is induced by acute stress.
Classic physiological validation of the restraint stress procedure was provided by the activation of HPA axis, which was evidenced by the increases of CT and P secretion in our animals. The basal and post-stress CT concentrations were similar to the data from female models that used E 2 -priming (Figueiredo et al., 2007; Kam et al., 2000) . The decrease of the plasma CT and cortisol induced by antalarmin has been reported extensively for stress models used in rodents (Jaszberenyi et al., 2007; Myers et al., 2005) and in non-human primate (French et al., 2007; Habib et al., 2000) .
Our data showed that antalarmin administration attenuated but did not block CT secretion which is possibly seen that this secretion seems also dependent on CRH-R 2. Previous studies have shown that CRH-R 1 and CRH-R 2 receptors exert complementary functions during the stress response (Bale et al., 2002) . Both CRH receptors have been shown to participate in this response but in different forms, CRH-R 1 has been shown to be fundamental to the onset of the stress response (Preil et al., 2001) , meanwhile CRH-R 2 has been involved in the recovery response (de Kloet et al., 2005) .
In a similar manner to the CT response, stress-induced P secretion was attenuated by antalarmin. This stress response has been reported in male rats exposed to metabolic (Elman and Breier, 1997) , restraint (Jaroenporn et al., 2007) , or electroshock stressors (Andersen et al., 2004) . This stress response has also been reported in female rats exposed to ether inhalation (Deis et al., 1989) and in ovariectomized monkeys replaced with E 2 subjected to immunological stress (Xiao et al., 1994) . Our results provide new evidence about the partial involvement of CRH-R 1 receptors in this stress response.
It has been shown that P secretion increases in response to stressors in cyclic (Boehm et al., 1982) and ovariectomized (Budec et al., 2002) female rats. Stress-induced progesterone secretion can be mediated solely by adrenal gland whereas occurs in ovariectomized prepubertal and adult female rats. Puberty in female is associated with changes of function and reactivity in the hypothalamus-pituitary-adrenal (HPA) axis (Romeo et al., 2004) . Progesterone has a biphasic effect on gonadotropin secretion (Everett, 1948) . It plays an important role in synchronizing and potentiating the preovulatory gonadotropin surge, ensurging a full ovulatory quota ova and limiting the gonadotropin surge to proestrus day (Brann and Mahesh, 1991) . It has been hypothesized that adrenal P plays a stimulatory and ovarian P plays an inhibitory action on gonadotropin secretion (Mahesh Fig. 5 -Effects of restraint stress (40 min) on progesterone (P) secretion in estrogen-primed ovariectomized rats previously treated with antalarmin (0.1 or 1 mg/kg i.v.) or vehicle. As control, a group no-stress was treated with vehicle. A (from 10 to 14 h) and B (from 10 to 18 h). Data are shown as mean ± SEM and were analyzed using the Mixed Linear Model. Significant differences: *stress vs. antalarmin and the control vehicle groups (p < 0.05); # stress vs. antalarmin groups (p < 0.05). † Control vehicle vs. antalarmin groups (p < 0.05). Group size = 10 animals.
and Brann, 1992) . The alteration of gonadotropin secretion that we observed with antalarmin administration may be mediated by decreasing of P secretion.
In summary, acute restraint stress modifies differently the pattern secretion of LH, PRL, FSH, CT and P in E 2 replaced ovariectomized rats. The secretion of LH, CT and P changes rapidly after the end of stress. However, the secretion of PRL and FSH occurs some hours later. This work shows that, CRH-R 1 antagonist reverses totally the increased secretion of LH and the delay of PRL secretion, but partially the increased secretion of CT and P. The effect on the FSH surge remains unchanged with administration of CRH-R 1 antagonist. The present study provides evidence that CRH-R 1 mediates, at least in part, hormonal alterations induced by acute stress. The anatomical sites that are responsible for these responses have not yet been identified.
Experimental procedures
Wistar adult female rats, weighing 200-220 g, were obtained from the animal house of the University of São Paulo at Ribeirão Preto and were kept in a central animal-care facility. These animals were housed in groups of five in plastic cages (50×32×17 cm) under a 12:12 h light⁄dark cycle (lights on at 06:00 h) and controlled temperature (22± 0.5°C). The air exchange rate in the animal house was ten-room volumes per hour. Food and water were provided ad libitum. Vaginal smears were taken daily and the surgical procedures were carried out during the metaestrus or diestrus phase. All of the protocols were followed in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals (USA) and approved by the Ethics Committee in Animal Research of the Medical School of Ribeirão Preto, University of São Paulo.
Experimental protocols
The rats were bilaterally ovariectomized under ketamine and xylazine anesthesia (100:20 mg/kg i.p. Agener®, Brazil and Dopaser®, Spain). After surgery, all of the rats were treated with a prophylactic dose of antibiotic (Pentabiotic®, Fort Dodge, Campinas, Brazil; 0.1 ml/rat) and the analgesic flunixin meglumine (2.5 mg/kg i.m., Banamine®, Schering-Plough, Rio de Janeiro, Brazil). The animals were primed with estradiol cypionate (10 μg/0.1 ml, s.c., Pfizer, Paulinia-SP, Brazil) at 10:00 h for 3 consecutive days, starting on the 5th day after the ovariectomy, which resembled hormonal secretion like to the proestrus phase. One day before the experiment, on the 7th day after the ovariectomy, a catheter (with an inner diameter of 0.51 mm and an outer diameter of 1.96 mm, Silastic® Dow Corning Co., Midland, Michigan, USA) filled with sterile saline (0.9% NaCl) was inserted through the external jugular vein into the right atrium, according to previously described technique, (Harms and Ojeda, 1974) under tribromoethanol anesthesia (1 ml/100 g body wt, i.p., 2.5% solution, Sigma-Aldrich, Milwaukee, USA).
4.1.1. Experiment 1 4.1.1.1. Antalarmin effects on hormonal secretion on the morning after restraint stress in estrogen-primed rats. The animals were Table 1 Mean ± SEM of plasma LH, CT, PRL, P and FSH from 10:00 to 18:00 h in control non-stress rats after vehicle or antalarmin i.v. injection. 18.9 ± 3 12.7 ± 2.2 9.6 ± 1.3 9.5 ± 1.7
Hormone
10.9 ± 2.7
10.6 ± 1.77 9.9 ± 1.8
Antalarmin 0.1 mg/kg 7.7 ± 1.4
12.1 ± 1.8
19.3 ± 4.4
15.3 ± 1.9
15.6 ± 3 15 ± 3.06
10.6 ± 1.9
11.3 ± 2.5 13 ± 4.2 13.2 ± 2.44 10.6 ± 2.7
Antalarmin 1 mg/kg 9.02 ± 1.9
23.22 ± 6.2 21.9 ± 3.8
24.3 ± 4.4 20 ± 3.9
10.2 ± 1.7
7.9 ± 1.1 6.6 ± 1.06
7.07 ± 1.18
6.8 ± 1.08
9.14 ± 1.47
FSH ng/ml Vehicle 8.7 ± 1.1 11.6 ± 2.2 10.8 ± 1.3 11.8 ± 2.2 8.9 ± 1.5
12.9 ± 1.9
10.1 ± 2.3
11.8 ± 1.5
12.2 ± 1.1 22.7 ± 1.6
17.1 ± 1.7
Antalarmin 0.1 mg/kg 7.3 ± 1.5
11.06 ± 2.1 12.1 ± 2.1 11.4 ± 3.4 9.9 ± 2.4
15.1 ± 2.9
8.1 ± 1.7
12.2 ± 2.2 13.4 ± 1.4
21.8 ± 1.9
18.7 ± 2.1
Antalarmin 1 mg/kg 9.6 ± 1.4
8.6 ± 1.45
9.6 ± 1.2 10.08 ± 1.8
9.1 ± 2.6
9.6 ± 1.5
10.2 ± 4.07
11.1 ± 1.7
12.5 ± 1.8
33.9 ± 3.02
16.1 ± 2.2 kept in individual cages and an extension of tubing PE-50 filled with sterile heparinized saline (150 I.U. heparin/ml) was connected to the jugular catheter, at 9:30 h approximately. The catheter was washed with the saline solution and the rats were left undisturbed in their cages for 30 min before the beginning of the experiment. At 10:00 h, a basal blood sample was collected and immediately the rats received either antalarmin (1 or 0.1 mg/kg i.v. Sigma-Aldrich, Steinheim, Germany) or vehicle (9% ethanol, 9% emulphor and 82% sterile water) (Broadbear et al., 2002) . Twenty minutes later the animals were submitted to restraint procedure that consisted of keep up them for 40 min in cylindrical plastic tubes (21 cm in length × 6 cm in diameter) with holes to allow access to fresh air. Seven blood samples (0.5 ml each) were collected through the jugular catheter from 10:00 until 14:00 h (10:00; 11:00; 11:15; 11:30; 12:00; 13:00 and 14:00 h). The volume withdrawn was immediately replaced with saline. The blood samples were centrifuged at 1200×g for 15 min at 4°C, and the plasma was separated and stored at −20°C until the measure of hormone levels by radioimmunoassay (RIA). The controls were left to roam freely around their enclosure following the injection of vehicle or antalarmin (1 or 0.1 mg/kg i.v.).
Experiment 2
4.1.2.1. Antalarmin effects on hormonal secretion during the afternoon after restraint stress in estrogen-primed rats. The same procedures described for Experiment 1 were also used in this; however, the blood samples were withdrawn from 10:00 to 18:00 h (10:00; 11:00; 14:00; 15:00; 16:00; 17:00 and 18:00 h).
Radioimmunoassay
The plasma concentrations of LH, FSH, and PRL were determined by double antibody RIA with specific antibodies provided by the National Hormone and Peptide Program (Harbor-UCLA Medical Center, USA). The iodinated hormones and the secondary antibody were produced by Dr. Franci's Laboratory (Medical School of Riberião Preto, University of São Paulo, Brazil). All of the samples were assayed in the same RIA. The lower limits of detection were 0.05 ng/ml for LH, 0.2 ng/ml for FSH, and 0.09 ng/ml for PRL. The intra-assay coefficients of variation for LH, FSH, and PRL were 4%, 3%, and 3.5%, respectively. The corticosterone-RIA used a specific antibody and standard from Sigma (St. Louis, MO, USA) and H 3− corticosterone from Amersham (Piscataway, NJ, USA). The lower limit of detection was 0.08 ng/ml, and the intra-assay and inter-assay variation coefficients were 4.5 and 11.4%, respectively. Plasma progesterone was determined by RIA using the Biochem ImmunoSystems MAIA® kit (Italy). All of the samples were assayed in the same assay. The lower limit of detection was 1.2 ng/ml and the intra-assay coefficient was 2.5%.
Statistical analysis
All of the data are presented as the mean ± standard error of mean (SEM). In both experiments each hormone was analyzed separately with three independent variables (stress, drug, and collection time). These multivariate analyses were performed using a Mixed Linear Model (fixed and random effects) because repeated observations were taken for each animal (Schall, 1991) . All statistical analyses were carried out using SAS (v.9.1, SAS, Cary, NC, USA), with the proc GLM and proc Mixed. The significance level was defined at 5%.
